Health Checkup, Medical Treatment & Elective Surgeries
MedEx connects you to JCI accredited world-class hospitals with outstanding certifications
Click here to login
Please select date*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
Top Searches :
Click here to login
Please select date and time*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
<p>Detects CDKN2A/2B gene deletions linked to cancer at MedEx Neo Clinic, Kathmandu.</p>
CDKN2A/2B (P16) Homozygous Gene Deletion Test at MedEx Neo Clinic, Kathmandu
This genetic test detects homozygous deletions in CDKN2A/2B genes, important tumor suppressor genes involved in cancer development. Conducted at MedEx Neo Clinic, Kathmandu.
Why is it important? Deletions in these genes are associated with aggressive cancers like gliomas and melanoma, impacting prognosis and treatment options.
Who should take this test? Patients with tumors suspected to have genetic alterations affecting CDKN2A/2B genes.
Test method: Fluorescence in situ hybridization (FISH) or PCR-based molecular testing.